Tisotumab Vedotin Boosts Survival in Chinese Subpopulation With Previously Treated Cervical Cancer
OncLive,
Image credit: © TensorSpark – stock.adobe.com Treatment with tisotumab vedotin-tftv (Tivdak) led to improved overall survival (OS…
Image credit: © TensorSpark – stock.adobe.com Treatment with tisotumab vedotin-tftv (Tivdak) led to improved overall survival (OS…
A priority review has been granted by the FDA for a supplemental biologics license application (sBLA) requesting to convert an…
The FDA has granted priority review to a supplemental biologics license application (sBLA) seeking to convert the accelerated…
Tisotumab vedotin (Tivdak) received accelerated approval from the FDA for the treatment of adult patients with recurrent or…